Jennifer Meade
About Jennifer Meade
Company
Jennifer Meade is currently employed at Bristol-Myers Squibb, a global biopharmaceutical company. Her role is based in New Brunswick, New Jersey.
Title
Jennifer holds the title of Associate Director, Contract Testing Lab QA at Bristol-Myers Squibb.
Previous Roles at Bristol-Myers Squibb
Jennifer Meade has held multiple roles at Bristol-Myers Squibb. From 2017 to 2019, she served as Compliance Lead in Analytical Science & Technology in New Brunswick, NJ. Prior to that, from 2014 to 2017, she worked as Scientist II/Continuous Improvement Lead in Molecular & Analytical Development in Hopewell, NJ.
Experience at Baxter Healthcare
At Baxter Healthcare, Jennifer served in two capacities. From 2006 to 2013, she was Quality Associate III in Quality Assurance in New Providence, NJ. Earlier, from 2003 to 2006, she worked as Research Associate II in Analytical R&D in Cherry Hill and New Providence, NJ.
Role at Wyeth-Ayerst ESI-Lederle
Jennifer worked as a Chemist in Analytical R&D at Wyeth-Ayerst ESI-Lederle from 2000 to 2003. Her tenure included roles in West Chester, PA, and Cherry Hill, NJ.
Education and Expertise
Jennifer Meade holds a Master of Science (MS) in Biotechnology from the Johns Hopkins University Advanced Academic Programs, achieved between 2018 to 2022. She also obtained a Bachelor of Science (BS) in Chemistry and Biochemistry from Delaware Valley College of Science and Agriculture, completed between 1997 to 2000.
Key Contributions at Bristol-Myers Squibb
Jennifer led the implementation of a comprehensive communication system for customers using contract testing laboratories. She was responsible for developing and maintaining quality metrics for laboratory service levels to drive continuous improvement. Additionally, she developed, negotiated, and maintained Quality Agreements and aligned collaborative partnerships with internal BMS Analytical functions.
Analytical Method Development Experience
Jennifer has extensive experience in HPLC and GC analytical method development, validation, and transfer for Active Pharmaceutical Ingredients (APIs), Finished Products, and Reference Standards.